vidarabine has been researched along with Bright Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lipton, JH; Pierratos, A; Tisler, A | 1 |
| Karadogan, I; Timuragaoglu, A; Undar, L | 1 |
| Chapman, A; Karmochkine, M; Piette, AM | 1 |
1 review(s) available for vidarabine and Bright Disease
| Article | Year |
|---|---|
[The glomerulopathies of cirrhosis of the liver].
Topics: Glomerulonephritis; Glomerulonephritis, Membranoproliferative; Hepatitis B; Hepatitis B Antigens; Humans; Interferon Type I; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Vidarabine | 1989 |
2 other study(ies) available for vidarabine and Bright Disease
| Article | Year |
|---|---|
Crescentic glomerulonephritis associated with p-ANCA positivity in fludarabine-treated chronic lymphocytic leukaemia.
Topics: Aged; Antibodies, Antineutrophil Cytoplasmic; Antineoplastic Agents; Female; Glomerulonephritis; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Vidarabine | 1996 |
Irreversible renal failure in a patient with chronic lymphocytic leukemia treated with fludarabine.
Topics: Acute Kidney Injury; Antimetabolites, Antineoplastic; Autoantibodies; Erythrocytes; Fatal Outcome; Glomerulonephritis; Humans; Immune Complex Diseases; Kidney Failure, Chronic; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Renal Dialysis; Salvage Therapy; Vidarabine | 1999 |